Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes BOOST: INTENSIFY PREMIX/ALL 2

NCT02762578 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT02762578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02762578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes BOOST: INTENSIFY PREMIX/ALL 2
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
May 3, 2016
Completion date
June 19, 2017
Enrollment
543 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2